MICHAEL BRENNAN: Open Payments
NPI 1629436407 · CANTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,014 in 43 payments from 16 companies in 2025. Trend: 2023 $1,645 · 2024 $1,556 · 2025 $1,014
Food & beverage: $1,014
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $169 |
| Collegium Pharmaceutical, Inc. | 7 | $141 |
| TerSera Therapeutics LLC | 4 | $122 |
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $111 |
| Abbott Laboratories | 1 | $104 |
| PFIZER INC. | 3 | $60 |
| Boston Scientific Corporation | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Averitas Pharma Inc. | 2 | $39 |
| Valinor Pharma, LLC | 2 | $38 |
Products named: Belbuca, Prialt, JOURNAVX, PROCLAIM, QULIPTA, NURTEC ODT, BOTOX, UBRELVY.
Industry payments across MI — which companies pay providers there.
